These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1401 related articles for article (PubMed ID: 33188364)
1. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Lim S; Bae JH; Kwon HS; Nauck MA Nat Rev Endocrinol; 2021 Jan; 17(1):11-30. PubMed ID: 33188364 [TBL] [Abstract][Full Text] [Related]
2. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes. Shao S; Yang Q; Pan R; Yu X; Chen Y Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management. Memon SS; Biswas DA Cureus; 2022 Nov; 14(11):e31895. PubMed ID: 36579192 [TBL] [Abstract][Full Text] [Related]
4. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? Filardi T; Morano S J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK; Banerjee M High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533 [TBL] [Abstract][Full Text] [Related]
6. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications. Drucker DJ Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32294179 [TBL] [Abstract][Full Text] [Related]
7. Diabetes and COVID-19: a major challenge in pandemic period? Chakraborty C; Sharma AR; Bhattacharya M; Sharma G; Agoramoorthy G; Lee SS Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11409-11420. PubMed ID: 33215463 [TBL] [Abstract][Full Text] [Related]
8. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives. Savoia C; Volpe M; Kreutz R Circ Res; 2021 Apr; 128(7):1062-1079. PubMed ID: 33793331 [TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481 [TBL] [Abstract][Full Text] [Related]
11. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. Hoevenaar M; Goossens D; Roorda J J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320979097. PubMed ID: 33283602 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
14. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression. Phyu Khin P; Cha SH; Jun HS; Lee JH Med Hypotheses; 2020 Nov; 144():110186. PubMed ID: 33254506 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation. Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317 [TBL] [Abstract][Full Text] [Related]
16. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662 [TBL] [Abstract][Full Text] [Related]
17. Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network. Gao Q; Zhang W; Li T; Yang G; Zhu W; Chen N; Jin H Sci Rep; 2022 Jan; 12(1):188. PubMed ID: 34996987 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine. Sayed S Prim Care Diabetes; 2021 Feb; 15(1):4-9. PubMed ID: 32912711 [TBL] [Abstract][Full Text] [Related]
19. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus. Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]